Exacerbation of genomic instability and radiosensitization upon RUNX3 or HMOX1 depletion in the presence of TGFβ. Exacerbation of genomic instability and.

Slides:



Advertisements
Similar presentations
Fig. 1 GBM TIMs expand to inhibit vaccine-induced T-cell mediated tumor cytolysis via PD-1/PD-L1 regulatory pathway. (A, D) CD163, DAPI, (B, E) PD-L1,
Advertisements

Adaptive Response to Low Dose Radiation
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Genomic Instability Delayed Genetic Effects.
NF1 silencing confers resistance of PC9 lung adenocarcinoma cells to erlotinib (erl). NF1 silencing confers resistance of PC9 lung adenocarcinoma cells.
Volume 116, Issue 5, Pages (May 1999)
Effects of SC144 on in vivo ovarian tumor.
Tumor development of poorly immunogenic LLC and B16F10 cells modified to produce GM-CSF was markedly inhibited. Tumor development of poorly immunogenic.
Volume 24, Issue 1, Pages (July 2013)
B7-H4 expression correlates with MHC-I expression and improved prognosis in patients with breast cancer. B7-H4 expression correlates with MHC-I expression.
Mechanisms of PARPi resistance in HR-deficient cells.
Caspase-1 from myeloid cells induces tumor proliferation via MyD88 oncogenic signaling. Caspase-1 from myeloid cells induces tumor proliferation via MyD88.
Volume 18, Issue 4, Pages (October 2010)
Microarray analysis of phospho-Twist1–responsive genes.
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites to Alter the Breast Cancer Cell Transcriptome  Hector L. Franco, Anusha Nagari, W. Lee Kraus 
Dan F. Spandau, Davina A. Lewis, Ally-Khan Somani, Jeffrey B. Travers 
Activated membrane signaling promotes survival in response to radiation. Activated membrane signaling promotes survival in response to radiation. Radiation.
Core promoter methylation in mediators of adipogenesis.
Volume 31, Issue 1, Pages (July 2008)
Pharmacological inhibition of DAO impairs DNA damage– and oncogene-induced senescence. Pharmacological inhibition of DAO impairs DNA damage– and oncogene-induced.
DNMT3A1 signatures are not recapitulated in AML.
DNMT3A2 signatures are coherently modified in AML.
Figure 2 Fingolimod impairs induction of activation markers on human monocytes Peripheral blood mononuclear cells from healthy donors were briefly exposed.
Fig. 5. Mutant KRAS increases HR capacity and MEKi decreases HR capacity in RAS mutant cells, causing increased DNA damage. Mutant KRAS increases HR capacity.
Assay of ROS accumulation in cells exposed to high levels of glucose.
Regulation of p53 by MDM2. p53 and MDM2 form an autoregulatory feedback loop. p53 stimulates the expression of MDM2; MDM2, in turn, inhibits p53 activity.
GR cells are dependent upon sustained CDC25C signaling as pharmacologic or genetic inhibition of CDC25C induce synthetic lethality. GR cells are dependent.
Methylation status of IGFBPL1 in human breast cancer.
A. A. XPCKD and KIN17KD HeLa cells grow poorly 2 weeks after transfection. Forty-eight hours after transfection, cells were plated at the same density.
Association between RB pathway alterations and poor prognosis in early-stage lung adenocarcinoma patients. Association between RB pathway alterations and.
Integrated mRNA and microRNA expression and DNA methylation clusters.
CXCL14-positive CAFs induce overexpression of LINC00092 in ovarian cancer. CXCL14-positive CAFs induce overexpression of LINC00092 in ovarian cancer. A,
SATB2-AS1 repressed Snail transcription depending on SATB2-mediated recruitment of HDAC1. SATB2-AS1 repressed Snail transcription depending on SATB2-mediated.
Heat map of genes for which CR significantly altered expression versus AL. Cluster analysis of genes significantly changed by the CR intervention compared.
Experimental metastasis inhibition by primary tumors is mediated by NK cells and IFNγ. Experimental metastasis inhibition by primary tumors is mediated.
EMT gene expression patterns of M-Wnt and E-Wnt cells in vitro and in vivo. EMT gene expression patterns of M-Wnt and E-Wnt cells in vitro and in vivo.
EN1 expression in breast cancer and clinical outcome.
IDO deficiency delays the development of pulmonary metastases.
Targeting HR via CDK inhibition resensitizes recurrent cultures to temozolomide (TMZ). Targeting HR via CDK inhibition resensitizes recurrent cultures.
ARID1A promotes DSB end resection.
Survival risk prediction analysis and application of the metastasis gene signature. Survival risk prediction analysis and application of the metastasis.
Extrinsic versus intrinsic activation of p16INK4a.
PD-1 expression in ovarian cancer.
Effect of siltuximab on paclitaxel sensitivity in ovarian cancer drug resistant cells. Effect of siltuximab on paclitaxel sensitivity in ovarian cancer.
RUNX3 depletion induces cellular senescence and inflammatory cytokine expression in cells undergoing TGFβ-mediated EMT. A, Cells were transfected with.
FGFR1 is dominantly expressed in mesenchymal-like KRAS-mutant lung cancer cell lines. FGFR1 is dominantly expressed in mesenchymal-like KRAS-mutant lung.
RUNX3 depletion induces cellular senescence in an ATM/ATR dependent, but p53-independent manner. RUNX3 depletion induces cellular senescence in an ATM/ATR.
p53 loss affects several steps of the metastatic process.
Anti-CD40 activates TAMs and recruits inflammatory monocytes.
SPARC is required for spontaneous metastasis
The effects of AZD1775 and olaparib on DNA damage response signaling.
Snail-induced multinucleation follows midbody persistence.
Apoptotic cell debris induces AXL-dependent cell migration.
The effect of TGFβ on the post-RT increase of Tregs in tumors.
Antibody-mediated blockade of the immune-inhibitory PD-1–PD-L1 signaling pathway prolongs survival in poly(I:C)-treated mice. Antibody-mediated blockade.
Flavopiridol inhibits rhabdoid cell survival and induces cell cycle arrest and apoptosis. Flavopiridol inhibits rhabdoid cell survival and induces cell.
Identification of RASA1- and NF1-mutated lung cancer cell lines in the CCLE dataset (accessed via the cBioPortal for Cancer Genomics at
p53β regulates cellular senescence.
Signals and transcription factors involved in B-cell PD-1 induction.
Mutational signature analysis of WES data from patients with advanced PDAC. A, Projection of signatures representing four main mutational processes identified.
FGF19 amplification in liver cancer cell lines is associated with response to NVP-BGJ398. FGF19 amplification in liver cancer cell lines is associated.
NUAK1 overexpression correlates with tumor progression, lymph node infiltrates, and reduced overall survival (OS) in human colorectal cancer. NUAK1 overexpression.
CASP8 mutations are associated with fewer CNAs and RAS family mutations. CASP8 mutations are associated with fewer CNAs and RAS family mutations. A, number.
Integrated analysis of gene expression and copy number alterations.
NSD2-mediated methylation of PTEN at K349 dictates cellular sensitivity to DNA-damaging agents. NSD2-mediated methylation of PTEN at K349 dictates cellular.
Transcriptome traits and clinical characteristics of TME phenotypes in the ACRG cohort. Transcriptome traits and clinical characteristics of TME phenotypes.
TME characteristics of TCGA-STAD subtype and cancer somatic genome.
Construction of TME signatures and functional annotation.
Sp1 complementation assay.
Presentation transcript:

Exacerbation of genomic instability and radiosensitization upon RUNX3 or HMOX1 depletion in the presence of TGFβ. Exacerbation of genomic instability and radiosensitization upon RUNX3 or HMOX1 depletion in the presence of TGFβ. A, Lung adenocarcinomas were stratified on the basis of TGFβ signature and RUNX3 expression levels utilizing median expression values. Copy number alterations are shown in the scatter plot with bar (mean ± SEM). B, Lung adenocarcinomas were stratified on the basis of TGFβ signature and RUNX3 expression levels utilizing median expression values. Mutations per megabase of the genome are shown in the scatter plot with bar (mean ± SEM). C, Kaplan–Meier survival curve of the indicated cohorts is shown. n = 181, P = 0.0955, HR = 1.845. Statistical analysis was done with the Mann–Whitney U test. D, A549 cells were subjected to control or RUNX3-KD and exposed to vehicle control or TGFβ for 48 hours. Cells were exposed to increasing doses of X-irradiation in clonogenic assay. E, For experiment described in D, percent survival was plotted relative to radiation-untreated controls. F, A549 cells were subjected to control or HMOX1-KD and exposed to TGFβ or vehicle control. Forty-eight hours following TGFβ addition, cells were exposed to increasing doses of X-irradiation. G, For experiment described in F, percent survival was plotted relative to radiation-untreated controls. H, RUNX3 provides defense against TGFβ-dependent promotion of cancer progression. Top, TGFβ signaling induces ROS production, which participates in redox signaling and promotes TGFβ-mediated EMT. However, RUNX3 mitigates the accumulation of excessive ROS via the transcriptional upregulation of the HMOX1 and thus curtails tumor progression. Under these conditions, where RUNX3 levels are intact, TGFβ-mediated EMT is associated with low levels of DNA damage and genomic instability. Bottom, in the absence of RUNX3, low HMOX1 levels perpetrate high levels of ROS, which promotes cancer progression by the induction of DNA damage and senescence. Cellular senescence, in turn, fuels the production of inflammatory cytokines that further amplify the pro-oncogenic state. The reinstatement of HMOX1 expression in RUNX3-depleted cells restored cellular ROS, rescued DNA damage and premature senescence in the presence of TGFβ. Thus, HMOX1 downregulation seems to be one of the major mechanisms by which genomic instability is brought about by the TGFβ exposure of RUNX3-deficient cells. Vaidehi Krishnan et al. Cancer Res 2018;78:88-102 ©2018 by American Association for Cancer Research